Who We Are

The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries.


The Medicines Patents & Licences Database
MPP’s patents and licences database, MedsPaL, is a resource that provides information on the intellectual property status of selected HIV, hepatitis C, tuberculosis and other patented essential medicines in low- and middle-income countries.
We are now including some patented medicines being tested for the treatment of COVID-19.


All MPP licences are publicly available in their entirety on our website. This is unprecedented in the pharmaceutical field.

MPP in Numbers

Hover over the numbers to find out more
10 patent holders with MPP signed agreements
31.4 million patient-years through MPP’s generic partners from January 2012 to December 2019
22 generic manufacturers and product developers sublicensed from the MPP
18 products licensed to the MPP
150+ ongoing pharmaceutical development projects
87% to 91%
87% to 91% of people living with HIV in developing countries covered by the MPP adult licences
92 to 131
92 to 131 countries covered by MPP adults licences
1.44 billion dollars saved, from January 2012 to December 2019
11.74 billion doses of treatment supplied till date

Latest News


See More


See More
“We support the engagement of all relevant organizations, such as WHO, UNAIDS, Gavi, the Global Fund, and Unitaid and initiatives, including the recent expansion of the Medicines Patent Pool, in their work to improve access for all to safe, effective, quali...”

This website uses cookies to ensure you get the best experience on our website. Learn More